[
Antonios V.S., A.A. Noel, J.M. Steckelberg, R.M. Wilson, J.N. Mandrekar, W.S. Harmsen and L.M. Baddour. 2006. Prosthetic vascular graft infection: a risk factor analysis using a casecontrol study. J. Infect. 53: 49–55.10.1016/j.jinf.2005.10.004
]Search in Google Scholar
[
Avşar M.K., H.H. Poyrazoglu, S. Demir and H. Atli. 2013. Early results of peripheral arterial performed using shelhigh no-react treated internal mammary arteries. Ital. J. Vasc. Endovasc. Surg. 20: 221–223.
]Search in Google Scholar
[
Bandyk D.F., T.M. Bergamini, E.V. Kinney, G.R. Seabrook and J.B. Towne. 1991. In situ replacement of vascular protheses infected by bacterial biofilms. J. Vasc. Surg. 13: 575–583.10.1016/0741-5214(91)90339-V
]Search in Google Scholar
[
Bozoglan O., B. Mese, E. Eroglu, S. Elveren, M. Gul, A. Celik, H.I. Yildirimdemir, H. Ciralik and A. Yasim. 2016. Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts? Surg. Today. 46: 363–370.10.1007/s00595-015-1141-325744711
]Search in Google Scholar
[
Bronk M. and A. Samet. 2008. Hospital enterococcal bacteremias. Post. Mikrobiol. 47: 339–344.
]Search in Google Scholar
[
Chiesa R., D. Astore, S. Frigerio, L. Garriboli, G. Piccolo, R. Castellano, M. Scalamogna, A. Odero, S. Pirrelli, G. Biasi and others. 2002. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir. Belg. 102: 238–247.
]Search in Google Scholar
[
Dünschede F., J. Stabrauskaite, G. Weisser, C. Espinola-Klein, B. Dorweiler and C.F. Vahl. 2015. Crural bypass for critical lower limb ischemia with Omniflow II prosthesis. Thorac. Cardiovasc. Surg. 64: 311–315.10.1055/s-0035-156003926291743
]Search in Google Scholar
[
Giacometti A., O. Cirioni, R. Ghiselli, L. Goffi, F. Mocchegiani, A. Riva, G. Scalise and V. Saba. 2000. Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. J. Antimicrob. Chemother. 46:751–756.10.1093/jac/46.5.75111062194
]Search in Google Scholar
[
Grubbs F.E. 1950. Sample criteria for testing outlying observations. Ann. Math. Stat. 21(1): 27–58.
]Search in Google Scholar
[
Herrera F.A., S. Kohanzadeh, Y. Nasseri, N. Kansal, E.L. Owens and R. Bodor. 2009. Management of vascular graft infections with soft tissue flap coverage: improving limb salvage rates – a veterans affairs experience. Am. Surg. 75: 877–881.10.1177/00031348090750100319886126
]Search in Google Scholar
[
Jensen L.P., M. Lepäntalo, J.E. Fossdal, O.C. Røder, B.S. Jensen, M.S. Madsen, O. Grenager, H. Fasting, H.O. Myhre, N. Baekgaard and others. 2007. Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomised study. Eur. J. Vasc. Endovasc. Surg. 34: 44–49.10.1016/j.ejvs.2007.01.01617400486
]Search in Google Scholar
[
Krasznai A.G., M. Snoeijs, M.P. Siroen, T. Sigterman, A. Korsten, F.L. Moll and L.H. Bouwman. 2016. Treatment of aortic graft infection by in situ reconstruction with Omniflow II biosynthetic prosthesis. Vascular. 24: 561–566.10.1177/170853811562119526647420
]Search in Google Scholar
[
Musci M., A. Amiri, H. Siniawski, J. Stein, Y. Weng and R. Hetzer. 2013. Further experience with the “no-react” bioprosthesis in patients with active infective endocarditis: 11-year single center results in 402 patients. Thorac Cardiovasc. Surg. 61: 398–408.10.1055/s-0033-133790323564537
]Search in Google Scholar
[
Palumbo R., P. Niscola, S. Calabria, S. Fierimonte, M. Bevilacqua, L. Scaramucci, B. Tolu, P. de Fabritiis and F. Bondanini. 2009. Long-term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron. Clin. Pract. 1132: 76–80.10.1159/00022853819602902
]Search in Google Scholar
[
Post S., T. Kraus, U. Müller-Reinartz, C. Weiss, H. Kortmann, A. Quentmeier, M. Winkler, K.J. Husfeldt and J.R. Allenberg. 2001. Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur. J. Vasc. Endovasc. Surg. 22: 226–231.10.1053/ejvs.2001.142411506515
]Search in Google Scholar
[
Schmitt D.D., D.F. Bandyk, A.J.P equet and J.B. Towne. 1986. Bacterial adherence to vascular prostheses. A determinant of graft infectivity. J. Vasc. Surg. 3: 732–740.10.1067/mva.1986.avs0030732
]Search in Google Scholar
[
Töpel I., T. Betz, C. Uhl, M. Wiesner, S. Bröckner and M. Steinbauer. 2012. Use of biosynthetic prosthesis (Omniflow II) to replace infected infrainguinal prosthetic grafts – first results. Vasa. 413: 215–220.10.1024/0301-1526/a00018822565623
]Search in Google Scholar
[
Werkmeister J.A., J.F. White, G.A. Edwards and J.A. Ramshaw. 1995. Early performance appraisal of the Omniflow II Vascular Prosthesis as an indicator of long-term function. J. Long Term. Eff. Med. Implants. 5: 1–10.
]Search in Google Scholar
[
Yasim A., M. Gul, H. Ciralik and Y. Ergun. 2006. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft. Eur. J. Vasc. Endovasc. Surg. 32: 425–430.10.1016/j.ejvs.2006.03.01416725356
]Search in Google Scholar
